Dysmenorrhea treatment with a single daily dose of rofecoxib
article
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
Single daily doses of 25 mg and 50 mg rofecoxib effectively reduced dysmenorrhea pain comparably to naproxen sodium, with fewer gastrointestinal side effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVES: To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea. METHODS: Fifty-five patients were included in this randomized, placebo-controlled, cross-over study. Patients were randomized to use placebo, naproxen sodium (550 mg), 25 and 50 mg doses of rofecoxib in various orders. Pain intensity, analgesic efficacy of drugs, total number of pills used and side effects were evaluated. RESULTS: Rofecoxib with daily single doses of 25 and 50 mg decreased the pain intensity in a manner similar to naproxen sodium. Most of the patients (85.45% and 96.46%) evaluated the analgesic efficacy of rofecoxib as 'perfectly effective'. Rofecoxib was found to be effective for pain relief both in primary and secondary dysmenorrhea. Gastrointestinal adverse effects were less than those with naproxen sodium. CONCLUSIONS: A 'one a day' dose of 25 mg rofecoxib is an effective choice with lower gastrointestinal adverse effects than naproxen sodium.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (26)
- Correlation between dysmenorrheic severity and prostaglandin production in women with endometriosis via openalex
- Dysmenorrhoea and Prostaglandins via openalex
- Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women via openalex
- Ibuprofen and Dysmenorrhea via openalex
- Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. via openalex
- Nonsteroidal antiinflammatory drugs and reproduction via openalex
- Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: Effect on prostaglandin levels in menstrual fluid via openalex
- W6600904930 via openalex
- W6654778910 via openalex
- doi:10.1016/s1071-5576(99)00034-9 via openalex
- doi:10.2165/00003495-200161060-00019 via openalex
- doi:10.7326/0003-4819-115-10-787 via openalex
- doi:10.2165/00003495-199958030-00016 via openalex
- doi:10.3949/ccjm.69.suppl_1.si31 via openalex
- doi:10.1016/s0002-9343(99)00114-x via openalex
- doi:10.1016/s0889-8553(05)70226-0 via openalex
- doi:10.1016/0002-9343(88)90473-1 via openalex
- doi:10.1016/s0140-6736(98)12154-2 via openalex
- doi:10.3109/03009749609097226 via openalex
- doi:10.1016/s0889-857x(05)70073-9 via openalex
- doi:10.1016/s0029-7844(99)00360-9 via openalex
- W22483630 via openalex
- doi:10.1358/mf.2000.22.5.796648 via openalex
- doi:10.3109/09513599509160464 via openalex
- doi:10.1016/0029-7844(95)00360-6 via openalex
- W2406695751 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-14T06:02:11.780192+00:00
License: CC0
· commercial use OK